Early-Stage drug safety trial halted in healthy volunteers
NCT ID NCT05740280
First seen Nov 01, 2025 · Last updated Jun 08, 2026 · Updated 32 times
Summary
This early-stage study aimed to check the safety and tolerability of an experimental drug called iCP-NI in healthy adults aged 18 to 55. Participants received either the drug or a placebo through an IV. The study was terminated early, so results are limited.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HEALTHY VOLUNTEERS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Labcorp Clinical Research Unit Inc.
Daytona Beach, Florida, 32117, United States
Conditions
Explore the condition pages connected to this study.